Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1926 1
1927 2
1930 1
1931 2
1933 1
1945 1
1947 1
1949 4
1950 3
1952 2
1953 2
1954 1
1955 1
1958 3
1959 3
1960 4
1961 1
1962 3
1963 2
1964 4
1965 6
1966 7
1967 11
1968 9
1969 7
1970 9
1971 8
1972 11
1973 7
1974 7
1975 11
1976 9
1977 7
1978 6
1979 22
1980 8
1981 10
1982 18
1983 17
1984 19
1985 27
1986 25
1987 23
1988 26
1989 16
1990 27
1991 25
1992 17
1993 17
1994 20
1995 19
1996 18
1997 26
1998 28
1999 24
2000 30
2001 26
2002 34
2003 35
2004 46
2005 48
2006 35
2007 47
2008 67
2009 64
2010 47
2011 61
2012 52
2013 76
2014 74
2015 84
2016 69
2017 69
2018 62
2019 59
2020 93
2021 79
2022 85
2023 74
2024 58

Text availability

Article attribute

Article type

Publication date

Search Results

1,890 results

Results by year

Filters applied: . Clear all
Page 1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
Makker V, Colombo N, Casado Herráez A, Santin AD, Colomba E, Miller DS, Fujiwara K, Pignata S, Baron-Hay S, Ray-Coquard I, Shapira-Frommer R, Ushijima K, Sakata J, Yonemori K, Kim YM, Guerra EM, Sanli UA, McCormack MM, Smith AD, Keefe S, Bird S, Dutta L, Orlowski RJ, Lorusso D; Study 309–KEYNOTE-775 Investigators. Makker V, et al. Among authors: smith ad. N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19. N Engl J Med. 2022. PMID: 35045221 Clinical Trial.
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. Among authors: smith ad. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.
Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies.
Motzer RJ, Taylor MH, Evans TRJ, Okusaka T, Glen H, Lubiniecki GM, Dutcus C, Smith AD, Okpara CE, Hussein Z, Hayato S, Tamai T, Makker V. Motzer RJ, et al. Among authors: smith ad. Expert Rev Anticancer Ther. 2022 Apr;22(4):383-400. doi: 10.1080/14737140.2022.2039123. Epub 2022 Apr 7. Expert Rev Anticancer Ther. 2022. PMID: 35260027 Free PMC article. Review.
The importance of vitamin B12 for individuals choosing plant-based diets.
Niklewicz A, Smith AD, Smith A, Holzer A, Klein A, McCaddon A, Molloy AM, Wolffenbuttel BHR, Nexo E, McNulty H, Refsum H, Gueant JL, Dib MJ, Ward M, Murphy M, Green R, Ahmadi KR, Hannibal L, Warren MJ, Owen PJ; CluB-12. Niklewicz A, et al. Among authors: smith ad. Eur J Nutr. 2023 Apr;62(3):1551-1559. doi: 10.1007/s00394-022-03025-4. Epub 2022 Dec 5. Eur J Nutr. 2023. PMID: 36469110 Free PMC article.
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination.
Arance A, de la Cruz-Merino L, Petrella TM, Jamal R, Ny L, Carneiro A, Berrocal A, Márquez-Rodas I, Spreafico A, Atkinson V, Costa Svedman F, Mant A, Khattak MA, Mihalcioiu C, Jang S, Cowey CL, Smith AD, Hawk N, Chen K, Diede SJ, Krepler C, Long GV. Arance A, et al. Among authors: smith ad. J Clin Oncol. 2023 Jan 1;41(1):75-85. doi: 10.1200/JCO.22.00221. Epub 2022 Jul 22. J Clin Oncol. 2023. PMID: 35867951 Clinical Trial.
Autoimmune hepatitis.
Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Heneghan MA, et al. Among authors: smith ad. Lancet. 2013 Oct 26;382(9902):1433-44. doi: 10.1016/S0140-6736(12)62163-1. Epub 2013 Jun 14. Lancet. 2013. PMID: 23768844 Review.
Editorial comment.
Leavitt DA, Smith AD. Leavitt DA, et al. Among authors: smith ad. J Urol. 2014 Mar;191(3):797. doi: 10.1016/j.juro.2013.10.152. Epub 2014 Jan 24. J Urol. 2014. PMID: 24461578 No abstract available.
Cysteine and obesity.
Elshorbagy AK, Smith AD, Kozich V, Refsum H. Elshorbagy AK, et al. Among authors: smith ad. Obesity (Silver Spring). 2012 Mar;20(3):473-81. doi: 10.1038/oby.2011.93. Epub 2011 May 5. Obesity (Silver Spring). 2012. PMID: 21546934 Free article. Review. No abstract available.
1,890 results